Original document(63 pages)  中文版
    The present invention is directed to compounds of formula (I): Wherein X<1>, X<2>, X<3>, X<4>, X<5>, X<6>, X<7>, X<8>, X<9>, X<10>, R<1>, R<2>, R<3>, R<4>, and n are as defined for formula I in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.
Application Number
申请号		 200580008454 Application Date
申请日		 2005.02.17
Title 名称 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists
Publication Number
公开号		 1934112 Publication Date
公开日		 2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D487/04;A61K31/4188;A61P1/00
Applicant(s) Name
申请人		 Astrazeneca AB
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 zoufeng lilian tao
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.